Abstract
Hemorrhagic cystitis is a common complication in hematopoietic stem cell transplant recipients. We report here a case of severe BKV-associated hemorrhagic cystitis who did not respond to intravenous cidofovir. Overt hematuria successfully resolved after a few days on hyperbaric oxygen and intravesical instillations of cidofovir, while BK viruria dropped after a few weeks and remained low. We review the literature for therapeutic options in hemorrhagic cystitis and try to explain how hyperbaric oxygen stimulates mucosal repair in the urinary bladder.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Intravesical
-
Adult
-
Antineoplastic Agents / adverse effects
-
Antiviral Agents / administration & dosage*
-
BK Virus
-
Cidofovir
-
Cystitis / etiology
-
Cystitis / therapy*
-
Cytomegalovirus Infections / therapy
-
Cytosine / administration & dosage
-
Cytosine / analogs & derivatives*
-
Hematopoietic Stem Cell Transplantation
-
Hematuria / etiology
-
Hematuria / therapy
-
Humans
-
Hyperbaric Oxygenation*
-
Leukemia, Myeloid, Acute / therapy
-
Leukemia, Myeloid, Acute / virology
-
Male
-
Organophosphonates / administration & dosage*
-
Polyomavirus Infections / complications
-
Polyomavirus Infections / therapy
-
Polyomavirus Infections / urine
-
Tumor Virus Infections / complications
-
Tumor Virus Infections / therapy
-
Tumor Virus Infections / urine
Substances
-
Antineoplastic Agents
-
Antiviral Agents
-
Organophosphonates
-
Cytosine
-
Cidofovir